o,o-diethyl o-3,5,6-trichloro-2-pyridyl phosphate has been researched along with Disease Models, Animal in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, J; Pope, C | 1 |
| Faria, M; Padrós, F; Prats, E; Raldúa, D; Soares, AM | 1 |
| Bar, D; Gaidukov, L; Kaufman, O; Levy-Nissenbaum, E; Naftali, E; Tabakman, R; Tawfik, DS; Yacobson, S | 1 |
| Cole, TB; Costa, LG; Furlong, CE; Jansen, K; Li, WF; Park, S | 1 |
| Darvesh, S; Duysen, EG; Li, B; Lockridge, O | 1 |
1 review(s) available for o,o-diethyl o-3,5,6-trichloro-2-pyridyl phosphate and Disease Models, Animal
| Article | Year |
|---|---|
The toxicity of mixtures of specific organophosphate compounds is modulated by paraoxonase 1 status.
Topics: Animals; Aryldialkylphosphatase; Carboxylesterase; Chlorpyrifos; Disease Models, Animal; Genotype; Insecticides; Mice; Mice, Knockout; Organophosphorus Compounds; Paraoxon; Tissue Distribution | 2010 |
4 other study(ies) available for o,o-diethyl o-3,5,6-trichloro-2-pyridyl phosphate and Disease Models, Animal
| Article | Year |
|---|---|
The cannabinoid receptor antagonist AM251 increases paraoxon and chlorpyrifos oxon toxicity in rats.
Topics: Amidohydrolases; Analysis of Variance; Animals; Arachidonic Acids; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Chlorpyrifos; Cholinesterase Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Endocannabinoids; Insecticides; Male; Monoacylglycerol Lipases; Neurotoxicity Syndromes; Paraoxon; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Rats; Rats, Sprague-Dawley; Time Factors; Tritium | 2015 |
Zebrafish is a predictive model for identifying compounds that protect against brain toxicity in severe acute organophosphorus intoxication.
Topics: Animals; Antidotes; Brain; Chlorpyrifos; Disease Models, Animal; Lethal Dose 50; Neuroprotective Agents; Organophosphate Poisoning; Zebrafish | 2017 |
In vivo administration of BL-3050: highly stable engineered PON1-HDL complexes.
Topics: Animals; Aryldialkylphosphatase; Chlorpyrifos; Disease Models, Animal; Enzyme Stability; Female; Glutathione; Humans; Injections, Intravenous; Lipoproteins, HDL; Male; Mice; Mice, Inbred C57BL; Organophosphates; Phosphatidylcholines; Protein Engineering; Recombinant Proteins | 2009 |
Sensitivity of butyrylcholinesterase knockout mice to (--)-huperzine A and donepezil suggests humans with butyrylcholinesterase deficiency may not tolerate these Alzheimer's disease drugs and indicates butyrylcholinesterase function in neurotransmission.
Topics: Acetylcholine; Acetylcholinesterase; Alkaloids; Alzheimer Disease; Animals; Butyrylcholinesterase; Chlorpyrifos; Cholinesterase Inhibitors; Disease Models, Animal; Donepezil; Dose-Response Relationship, Drug; Female; Humans; Indans; Male; Mice; Mice, Knockout; Neurotoxicity Syndromes; Piperidines; Sesquiterpenes; Synaptic Transmission | 2007 |